“…Whether DRB15040ء molecules are more effective than other DR molecules in presenting M. leprae antigens and eliciting stronger cellular immune response remains to be studied further. Several epidemiologic studies reported significant associations of HLA-DR2 (DRB1)51ء with susceptibility to leprosy in Turkish, Thai, Korean, and Brazilian populations [6,8,12,14,15], with HLA-DRB11051ء (OR ϭ 4.6) in Japan [7], with DRB11051ء (OR ϭ 10.9) and with DRB12051ء (OR ϭ3.0) in India [10,11] (Table 4). On the contrary, our results only showed a very weak association with any subset of HLA-DR2 (DRB1,1051ء OR ϭ 2.0, p ϭ 0.073; DRB1,51ء OR ϭ 1.73, p ϭ 0.079; DR2 (combined DRB1,1051ء DRB12051ء and DRB1,)2061ء OR ϭ 1.52, p ϭ 0.09).…”